198 related articles for article (PubMed ID: 30249688)
21. Analysis of a fungus-specific transcription factor family, the Candida albicans zinc cluster proteins, by artificial activation.
Schillig R; Morschhäuser J
Mol Microbiol; 2013 Sep; 89(5):1003-17. PubMed ID: 23844834
[TBL] [Abstract][Full Text] [Related]
22. SAGA/ADA complex subunit Ada2 is required for Cap1- but not Mrr1-mediated upregulation of the Candida albicans multidrug efflux pump MDR1.
Ramírez-Zavala B; Mogavero S; Schöller E; Sasse C; Rogers PD; Morschhäuser J
Antimicrob Agents Chemother; 2014 Sep; 58(9):5102-10. PubMed ID: 24936593
[TBL] [Abstract][Full Text] [Related]
23. Mutations in transcription factor Mrr2p contribute to fluconazole resistance in clinical isolates of Candida albicans.
Wang Y; Liu JY; Shi C; Li WJ; Zhao Y; Yan L; Xiang MJ
Int J Antimicrob Agents; 2015 Nov; 46(5):552-9. PubMed ID: 26404130
[TBL] [Abstract][Full Text] [Related]
24. Mediator Tail Module Is Required for Tac1-Activated
Liu Z; Myers LC
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807920
[TBL] [Abstract][Full Text] [Related]
25. Palmarumycin P3 Reverses Mrr1-Mediated Azole Resistance by Blocking the Efflux Pump Mdr1.
Song M; Zhang M; Lu J; Xie F; Song J; Luan X; Hou X; Lou H; Chang W
Antimicrob Agents Chemother; 2022 Mar; 66(3):e0212621. PubMed ID: 35041505
[TBL] [Abstract][Full Text] [Related]
26. STB5 is a negative regulator of azole resistance in Candida glabrata.
Noble JA; Tsai HF; Suffis SD; Su Q; Myers TG; Bennett JE
Antimicrob Agents Chemother; 2013 Feb; 57(2):959-67. PubMed ID: 23229483
[TBL] [Abstract][Full Text] [Related]
27. UPC2 is universally essential for azole antifungal resistance in Candida albicans.
Vasicek EM; Berkow EL; Flowers SA; Barker KS; Rogers PD
Eukaryot Cell; 2014 Jul; 13(7):933-46. PubMed ID: 24659578
[TBL] [Abstract][Full Text] [Related]
28. Fcr1p inhibits development of fluconazole resistance in Candida albicans by abolishing CDR1 induction.
Shen H; An MM; Wang de J; Xu Z; Zhang JD; Gao PH; Cao YY; Cao YB; Jiang YY
Biol Pharm Bull; 2007 Jan; 30(1):68-73. PubMed ID: 17202662
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
[TBL] [Abstract][Full Text] [Related]
30. The zinc cluster transcription factor Tac1p regulates PDR16 expression in Candida albicans.
Znaidi S; De Deken X; Weber S; Rigby T; Nantel A; Raymond M
Mol Microbiol; 2007 Oct; 66(2):440-52. PubMed ID: 17897373
[TBL] [Abstract][Full Text] [Related]
31. Synthetic Organotellurium Compounds Sensitize Drug-Resistant Candida albicans Clinical Isolates to Fluconazole.
Reis de Sá LF; Toledo FT; Gonçalves AC; Sousa BA; Dos Santos AA; Brasil PF; Duarte da Silva VA; Tessis AC; Ramos JA; Carvalho MA; Lamping E; Ferreira-Pereira A
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821447
[TBL] [Abstract][Full Text] [Related]
32. Expression of Major Efflux Pumps in Fluconazole-Resistant Candida albicans.
Pourakbari B; Teymuri M; Mahmoudi S; Valian SK; Movahedi Z; Eshaghi H; Mamishi S
Infect Disord Drug Targets; 2017; 17(3):178-184. PubMed ID: 28558643
[TBL] [Abstract][Full Text] [Related]
33. The RTA3 Gene, Encoding a Putative Lipid Translocase, Influences the Susceptibility of Candida albicans to Fluconazole.
Whaley SG; Tsao S; Weber S; Zhang Q; Barker KS; Raymond M; Rogers PD
Antimicrob Agents Chemother; 2016 Oct; 60(10):6060-6. PubMed ID: 27480868
[TBL] [Abstract][Full Text] [Related]
34. Candida albicans Zn Cluster Transcription Factors Tac1 and Znc1 Are Activated by Farnesol To Upregulate a Transcriptional Program Including the Multidrug Efflux Pump
Liu Z; Rossi JM; Myers LC
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104273
[TBL] [Abstract][Full Text] [Related]
35. Inducible and constitutive activation of two polymorphic promoter alleles of the Candida albicans multidrug efflux pump MDR1.
Sasse C; Schillig R; Reimund A; Merk J; Morschhäuser J
Antimicrob Agents Chemother; 2012 Aug; 56(8):4490-4. PubMed ID: 22615278
[TBL] [Abstract][Full Text] [Related]
36. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
37. Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance.
Znaidi S; Weber S; Al-Abdin OZ; Bomme P; Saidane S; Drouin S; Lemieux S; De Deken X; Robert F; Raymond M
Eukaryot Cell; 2008 May; 7(5):836-47. PubMed ID: 18390649
[TBL] [Abstract][Full Text] [Related]
38. Multidrug-resistant transporter mdr1p-mediated uptake of a novel antifungal compound.
Sun N; Li D; Fonzi W; Li X; Zhang L; Calderone R
Antimicrob Agents Chemother; 2013 Dec; 57(12):5931-9. PubMed ID: 24041896
[TBL] [Abstract][Full Text] [Related]
39. Vanillin confers antifungal drug synergism in Candida albicans by impeding CaCdr2p driven efflux.
Saibabu V; Fatima Z; Singh S; Khan LA; Hameed S
J Mycol Med; 2020 Apr; 30(1):100921. PubMed ID: 31937429
[TBL] [Abstract][Full Text] [Related]
40. Antifungal effect of Echinophora platyloba on expression of CDR1 and CDR2 genes in fluconazole-resistant Candida albicans.
Khajeh E; Hosseini Shokouh SJ; Rajabibazl M; Roudbary M; Rafiei S; Aslani P; Farahnejad Z
Br J Biomed Sci; 2016; 73(1):44-8. PubMed ID: 27182677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
